| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Soumitra Das, Sumesh T Purushothaman, Malathesh Bc, Seshadri Sekhar Chatterjee, Arjun Kartha, Varun Raja. Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS). Asian journal of psychiatry. vol 30. 2019-03-15. PMID:28711682. |
oral asenapine overdose leading to neuroleptic malignant syndrome (nms). |
2019-03-15 |
2023-08-13 |
Not clear |
| Tatsuhiko Anzai, Kunihiko Takahashi, Michiko Watanab. Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database. Psychiatry and clinical neurosciences. vol 73. issue 1. 2019-01-28. PMID:30375086. |
this study evaluates reports on neuroleptic malignant syndrome (nms) as an adverse event associated with the use of atypical antipsychotic agents (aaa) in japan. |
2019-01-28 |
2023-08-13 |
Not clear |
| Théo Korchia, Graham Blackman, Michel Cermolacce, Raphaëlle Richier. Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose. BMJ case reports. vol 2018. 2018-12-11. PMID:30076161. |
neuroleptic malignant syndrome (nms) is a potentially lethal adverse drug reaction. |
2018-12-11 |
2023-08-13 |
Not clear |
| Devashish Desai, Kartik Gupta, Rohit Kumar, Ashutosh Biswa. Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis. BMJ case reports. vol 2018. 2018-11-27. PMID:30100569. |
we managed her as a case of life-threatening neuroleptic malignant syndrome (nms) requiring mechanical ventilation, bromocriptine and other supportive care. |
2018-11-27 |
2023-08-13 |
Not clear |
| E M Peter-Ros. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders. Medical hypotheses. vol 113. 2018-10-15. PMID:29523295. |
snord115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-n-methyl-d-aspartate receptor (nmdar) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (nms) if environmentally triggered. |
2018-10-15 |
2023-08-13 |
Not clear |
| Michael R Ware, David B Feller, Karen L Hal. Neuroleptic Malignant Syndrome: Diagnosis and Management. The primary care companion for CNS disorders. vol 20. issue 1. 2018-08-09. PMID:29325237. |
to provide an overview of neuroleptic malignant syndrome (nms) for the general practitioner with the most up-to-date information on etiology, workup, and management. |
2018-08-09 |
2023-08-13 |
Not clear |
| Raj Velamoo. Neuroleptic malignant syndrome: A neuro-psychiatric emergency: Recognition, prevention, and management. Asian journal of psychiatry. vol 29. 2018-06-22. PMID:29061403. |
neuroleptic malignant syndrome (nms) is a life threatening complication of antipsychotic therapy. |
2018-06-22 |
2023-08-13 |
Not clear |
| Nicole M Schreiner, Samuel Windham, Andrew Barke. Atypical Neuroleptic Malignant Syndrome: Diagnosis and Proposal for an Expanded Treatment Algorithm: A Case Report. A & A case reports. vol 9. issue 12. 2018-05-17. PMID:28767476. |
neuroleptic malignant syndrome (nms) in the absence of an elevated creatine kinase is atypical and more difficult to diagnose. |
2018-05-17 |
2023-08-13 |
Not clear |
| Naoto Mizumura, Masato Uematsu, Aya Ito, Satoshi Okumura, Hiromitsu Maehira, Masao Ogawa, Masayasu Kawasak. "Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours. Internal medicine (Tokyo, Japan). vol 56. issue 22. 2018-05-14. PMID:28943586. |
neuroleptic malignant syndrome (nms) with characteristic symptoms is a potentially lethal reaction to antipsychotic drugs. |
2018-05-14 |
2023-08-13 |
Not clear |
| Neera Ghaziuddin, Melissa Hendriks, Paresh Patel, Lee E Wachtel, Dirk M Dhossch. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. Journal of child and adolescent psychopharmacology. vol 27. issue 4. 2018-04-02. PMID:28398818. |
to describe the presentation of neuroleptic malignant syndrome (nms) and malignant catatonia (mc) in children and adolescents. |
2018-04-02 |
2023-08-13 |
Not clear |
| P Casas Reza, M Gestal Vázquez, Á Outeiro Rosato, S López Álvarez, P Diéguez Garcí. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report. Revista espanola de anestesiologia y reanimacion. vol 64. issue 2. 2018-03-29. PMID:27424873. |
among their adverse effects is the ability to trigger a neuroleptic malignant syndrome (nms). |
2018-03-29 |
2023-08-13 |
Not clear |
| Usman Halim, Sanil Ajwani, Martyn Lovel. Neuroleptic Malignant Syndrome Following Bilateral Cemented Total Hip Replacements. Bulletin of the Hospital for Joint Disease (2013). vol 75. issue 4. 2018-02-16. PMID:29151017. |
neuroleptic malignant syndrome (nms) is a rare, serious complication caused by neuroleptic medications. |
2018-02-16 |
2023-08-13 |
Not clear |
| Scott Cherry, Dan Siskind, Valeria Spivak, Daniel Wysoczanski, Priyangika Halangod. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone? Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. vol 24. issue 6. 2018-02-12. PMID:27194777. |
however, one potentially lethal side effect of clozapine, as with other antipsychotics, is neuroleptic malignant syndrome (nms) which could present differently in clozapine therapy. |
2018-02-12 |
2023-08-13 |
Not clear |
| F Leenhardt, D Perier, V Pinzani, I Giraud, M Villiet, A Castet-Nicolas, V Gourhant, C Breuke. Pharmacist intervention to detect drug adverse events on admission to the emergency department: Two case reports of neuroleptic malignant syndrome. Journal of clinical pharmacy and therapeutics. vol 42. issue 4. 2018-01-26. PMID:28488314. |
neuroleptic malignant syndrome (nms) is a rare but severe adverse effect of antipsychotic drugs. |
2018-01-26 |
2023-08-13 |
Not clear |
| Fan Zhang, Parisa Kanzali, Vadim Rubin, Chris Paras, Joel Goldma. Neuroleptic malignant syndrome with thyroid disorder: An unusual case report. Medicine. vol 96. issue 39. 2017-10-06. PMID:28953679. |
neuroleptic malignant syndrome (nms) is a life threatening neurologic emergency associated with neuroleptic or antipsychotic agent use. |
2017-10-06 |
2023-08-13 |
Not clear |
| Justine Wittenauer Welsh, A Umair Janjua, Steven J Garlow, Laurie McCormick, Mustafa M Husain, Daniel F Maixner, Richard D Weiner, Adriana P Hermid. Use of Expert Consultation in a Complex Case of Neuroleptic Malignant Syndrome Requiring Electroconvulsive Therapy. Journal of psychiatric practice. vol 22. issue 6. 2017-09-26. PMID:27824784. |
our team at emory university hospital contacted experts at the national network of depression centers (nndc) for clinical guidance concerning a patient with schizophrenia hospitalized in the intensive care unit with a complex case of prolonged delirium secondary to neuroleptic malignant syndrome (nms). |
2017-09-26 |
2023-08-13 |
Not clear |
| C Khouri, S Planès, S Logerot, C Villier, M Mallare. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties]. L'Encephale. vol 42. issue 3. 2017-09-20. PMID:26923996. |
neuroleptic malignant syndrome (nms) is an uncommon but potentially fatal adverse effect of neuroleptic drugs. |
2017-09-20 |
2023-08-13 |
Not clear |
| Ronald J Gurrer. A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency. Acta psychiatrica Scandinavica. vol 135. issue 5. 2017-09-18. PMID:28144982. |
to examine sex and age distributions in neuroleptic malignant syndrome (nms) patients based on a systematic literature review. |
2017-09-18 |
2023-08-13 |
Not clear |
| Dominic J Pileggi, Aaron M Coo. Neuroleptic Malignant Syndrome. The Annals of pharmacotherapy. vol 50. issue 11. 2017-06-29. PMID:27423483. |
to review evidence for the treatment of neuroleptic malignant syndrome (nms) and to discuss how to rechallenge patients with neuroleptics when continued pharmacotherapy for chronic psychological illness is required. |
2017-06-29 |
2023-08-13 |
Not clear |
| L Bonanni, R Di Giacomo, A D'Amico, V Frazzini, R Franciotti, L Manzoli, A Thomas, M Onofr. Akinetic crisis in dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry. vol 87. issue 10. 2017-06-06. PMID:27068351. |
it is unclear, however, whether the neuroleptic hypersensitivity implies an increased incidence of neuroleptic malignant syndrome (nms) or of akinetic crisis (ac), which are expressions of the same possibly lethal clinical event, and whether ac in dlb can appear independently of neuroleptic treatment. |
2017-06-06 |
2023-08-13 |
Not clear |